nLIGHT's $600M Laser-Weapon Win Collides with a Sudden China Optics Shock

A record Q2 and a transformational Joint Laser Weapon System award — undercut within weeks by a China supply-chain rupture that knocks ~$17M out of Q3.

LASR · Earnings Call · 2026-08-06

From HELSI to JLWS: the arc closes

On the surface, nLIGHT's Q2 was all green: “Q2 represented another strong quarter of execution for nLIGHT with revenue, gross margin and adjusted EBITDA at or above our expectations.” — Scott Keeney, Chairman and CEO · 2026-08-06 Record total revenue of $82.6M (+34% YoY), record product revenue, record A&D product revenue (+72%), and a record $20.7M of cash from operations. But the real change is the pivot underneath: the Laser Weapon System went from demonstration science to a production contract. The Joint Laser Weapon System (JLWS) award — a multiyear Department of War agreement with a ceiling north of $600M (pegged at $627M, ~74% of the two-vendor $847M program) — shifts nLIGHT's directed-energy work from HELSI-era prototypes toward build-at-scale weapon systems. Scott Keeney tied it directly to the platform: “HADES was instrumental in helping us win the recent Joint Laser Weapon System, or JLWS award, a new multiyear DoW agreement with a contract ceiling of over $600 million” (6990095513901787932). The JLWS contribution starts this quarter and ramps hard in 2027. This is the close of a loop management flagged last fall. Asked in November how new orders would fill the HELSI-2 wind-down, Joe Corso answered “based on what we are working on today, the hole is already filled” — Joseph Corso, CFO · 2025-11-07. JLWS is that fill, and on this call he was explicit:

the win with JLWS will more than make up for that as we get into 2027.
Joseph Corso, CFO · 2026-08-06

The editorial keyword trajectory makes the hand-off visible: HELSI 2 crested at 304 momentum in Q4 2025 and has been sliding since (it now lands as a top decliner), while the HADES platform and the weapon-system program take the top of the chart. The 1-MW HELSI-2 delivery remains on track for late 2026 — “on track” was the repeated phrase — but the company's center of gravity has clearly moved from demo to deployment.

The China rupture that nobody saw coming

The quarter's true surprise is a brand-new, company-unique risk: supply chain challenges out of China. This keyword did not exist in any of the prior twelve quarters' editorial sets, yet it now sits near the top of the call — paired, tellingly, with the fresh mitigation strategy keyword. China's heightened scrutiny of dual-use optics, “materials where China has built out an outsized portion of the overall supply chain,” is delaying a narrow slice of the bill of materials — enough to push roughly $17M of third-quarter product revenue out to future quarters. The optics, per Scott, are “not specialized components”; scale of the BOM impact is small, but any missing piece halts a build. Joe's timeline makes it plain how sudden this is:

This has been a very recent development just over the past handful of weeks as this started to crop up.
Joseph Corso, CFO · 2026-08-06

The guidance consequence is stark: Q3 revenue guided to $63–73M (down from the record $82.6M), product gross margin to 34–40% on lower factory absorption, adjusted EBITDA collapsing to $1–7M. The sharpest contrast is with management's own prior framing. Back in May 2025, discussing tariffs, Joe identified the China-levered cost exposure and said it “disproportionately affects our industrial fiber laser business” (499596780955470746) — a cost-line concern, manageable via duty reclaims and shifting production to Thailand. Today it is a physical supply disruption to the very commercial product lines the company has been trying to grow. Notably, defense itself is “largely unaffected” — the initial JLWS work is “all systems go” — but some commercial items feeding defense carry indirect exposure. The company's insistence that “the forecast is still strong. Backlog is strong” (5093211230664642489) is the bull case; the bear case is that the BOM percentage understates how embedded China is in the optics chain, and requalification “will take months to quarters.”

What the tape is pricing

The market has not waited for clarity. LASR is down 32% in the last two weeks and ~44% off its May 11 peak — the supply shock landing right as a record quarter and a flagship weapon-system win hit the wire. The broader laser complex shows the same rotation: “High power laser” is a 360-day advancer (+4.5x led by AAOI/LITE/IPGP) but a 90- and 30-day decliner, and space-domain names have rolled over in 90-day decliners. The directed-energy theme itself is broad and real — KTOS flagged weapon-system demand and OSS cited Golden Dome this same week — but the valuation had sprinted far ahead of the fundamentals: price-to-revenue surged to 11.1x, up ~5x year-over-year, while total revenue reached $80M in Q1 2026 (+55% yoy) yet operating income still sat at a ~$1M loss (Total Revenue). Gross margin has recovered to ~33% — up 6.4pp yoy (Gross Margin) — but the momentum story now hinges on whether the $17M is a one-quarter “timing” gap or a signal of deeper China leverage. The balance sheet is the unlikely hero: $347M of effective net cash after the February equity raise gives nLIGHT the runway to requalify suppliers, redesign products, and cross the chasm to 2027, when JLWS replaces HELSI-2 and then some. For a $4B company with a $600M+ directed-energy program of record ahead, the China optics detour is most plausibly a shallow, quarterly scar on a structurally louder story — but the tape, down 44% from the peak and off 32% in a fortnight, is voting for skepticism until the optics start to flow again.